The next five years will be a critical period for

2022-08-02
  • Detail

The next five years will be a critical period for the development of China's pharmaceutical packaging industry. The annual GDP of China's pharmaceutical packaging materials will quickly exceed 20billion yuan in the maintenance and precautions for the use of short-term cold and hot impact testing machines. Such a large cake will make enterprises happy to get a part of it. However, there are only no more than 10 companies in the world that have developed such materials. At present, the existing packaging materials of drug packaging materials enterprises are backward and the market is quite chaotic. In particular, compared with the emerging new dosage forms, the matching drug packaging materials are too slow to follow up, which makes them unable to be so proud of the market

some experts predict that the next five years will be a critical period for the rapid development of China's pharmaceutical packaging industry. At present, the annual output value of China's pharmaceutical packaging industry is about 15billion yuan, which can only meet about 80% of the needs of domestic pharmaceutical enterprises, which promotes the rapid development of the plastic pharmaceutical packaging industry in recent years. However, it is for this reason that some software conditions matching this pharmaceutical peripheral industry have lagged behind and can not keep up with its development pace. At present, the compatibility test between new pharmaceutical preparations and new plastic packaging materials needs to be improved urgently in China. A relevant person from Nanfang Packaging Co., Ltd. said: "we usually do such tests for our customers now. The cycle is very long, and the investment in human and material resources is also very large‘ It is reported that there are not many domestic pharmaceutical packaging material manufacturers capable of undertaking such businesses, such as Nanfang packaging, whose production and sales data are low

it is understood that most of the existing plastic drug packaging material production enterprises in China are township collective enterprises, which are small in scale, low in personnel quality, equipment, technology and management, and unstable in product quality, resulting in disordered competition in the market. In order to reduce costs, some enterprises secretly buy a large number of low-cost and low-quality products. For example, the cost of the same kind of composite membrane produced in the clean workshop is about 22000 yuan/ton, while that produced in the 'underground factory' is no more than 18000 yuan/ton

Xinchang County, Zhejiang Province, is known as the 'hometown of capsules' in China. In the 1980s, its annual output once accounted for 1/3 of the national output. However, of the 327 capsule manufacturing enterprises in Xinchang County, 299 are undocumented, and 90% of them are in the "low, small and scattered" business situation. More than 40% of the capsule manufacturing enterprises belong to individual enterprises, and family workshops occupy the dominant position

it is understood that at present, some large-scale enterprises are powerless to deal with the chaotic market situation. Only in this way can their users select products and equipment that are more suitable for themselves. They have begun to seek diversified development and turned to exploring packaging business opportunities in the food industry. As for the expansion of drug packaging production, they believe that they still need to wait for the country to further rectify and standardize the market

Copyright © 2011 JIN SHI